Disease landscape

Cervical Cancer clinical trials

Get alerts when Cervical Cancer trials change

721 active trials 389 recruiting 49 Phase 3 415 sponsors 96 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days showing 55 of 96 changes on 20 trials

2026-09-12
Recruitment suspended
Recruitment suspended: Sponsor stopped the study.
NCT07181720 CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · Chongqing Precision Biotech Co., Ltd · Phase 1
2026-09-16
Trial terminated
Trial terminated: PI Request
Primary completion confirmed: August 2026 (last estimated December 2026)
NCT03634267 MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA… · M.D. Anderson Cancer Center · Phase 1
2026-08-25
Trial terminated
Primary completion moved earlier: 2029-12-31 → 2026-07-01
Completion moved earlier: 2030-12-31 → 2026-07-31
NCT03356795 Intervention of CAR-T Against Cervical Cancer · Shenzhen Geno-Immune Medical Institute · Phase 1/2
2026-08-25
Trial terminated
Primary completion moved earlier: 2029-12-31 → 2026-07-01
Completion moved earlier: 2030-12-31 → 2026-07-31
NCT03362619 Engineered Immune Effectors Against Cervical Cancer · Shenzhen Geno-Immune Medical Institute · Phase 1/2
2026-08-20
Withdrawn before enrolling
Trial withdrawn: Study withdrawn prior to participant enrollment due to lack of study product.
Primary completion pushed: 2026-07-31 → 2026-12-31
Enrollment reduced: 27 → 0 participants
Sponsor changed: Weill Medical College of Cornell University → University of California, San Diego
Completion pushed: 2026-07-31 → 2026-12-31
NCT07090174 CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among… · University of California, San Diego · Phase 2
2026-09-15
Primary completion pushed: 2026-06-30 → 2026-12-31
NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in… · OncoC4, Inc. · Phase 1/2
2026-09-05
Primary completion pushed: 2027-02 → 2029-06
Primary endpoint(s) modified
Enrollment increased: 495 → 575 participants
Interventions modified
Completion pushed: 2027-04 → 2029-06
Trial arms changed: 9 → 11
NCT06400472 A Study of Sofe-M in Participants With Selected Advanced Solid Tumors · Eli Lilly and Company · Phase 1
2026-09-11
Primary completion pushed: 2026-07 → 2027-12
Completion pushed: 2026-07 → 2028-07
NCT04865887 Pembrolizumab and Lenvatinib in Advanced Cervical Cancer · Georgetown University · Phase 2
2026-08-19
Primary completion pushed: 2025-12-30 → 2027-12-30
NCT05277688 Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer… · Ruijin Hospital · Phase 3
2026-09-04
Primary completion pushed: 2032-10-07 → 2033-03-07
Completion pushed: 2032-10-07 → 2033-03-07
NCT05521997 Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Washington University School of Medicine · Phase 2
2026-08-26
Primary completion pushed: 2026-09-01 → 2028-09-01
Completion pushed: 2028-12-31 → 2030-12-31
NCT05483491 KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer · Christian Hinrichs · Phase 1
2026-09-02
Primary completion pushed: 2027-02 → 2027-10-01
Primary endpoint(s) modified
Completion pushed: 2027-05 → 2028-03-31
NCT07520188 C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE'… · UNC Lineberger Comprehensive Cancer Center
2026-09-01
Primary completion pushed: 2026-11-04 → 2027-11-04
Completion pushed: 2027-11-04 → 2028-11-11
NCT06669533 Use Misoprostol to Optimize Prevention of Cervical Cancer · University of Alabama at Birmingham
2026-08-18
Primary completion pushed: 2027-03-25 → 2030-03-25
Completion moved earlier: 2032-03-25 → 2031-03-25
NCT05463796 InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer · Dana-Farber Cancer Institute
2026-09-03
Primary endpoint(s) modified
Trial completed
Primary completion confirmed: June 2026 (last estimated June 2027)
NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in… · Sensei Biotherapeutics, Inc. · Phase 1/2
2026-08-22
Primary endpoint(s) modified
Recruitment opened
Enrollment increased: 56 → 299 participants
Trial sites expanded: 0 → 3 locations
Primary completion moved earlier: 2028-08 → 2027-08
Trial arms changed: 2 → 3
NCT07623369 A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors · Huahui Health · Phase 1
2026-08-19
Primary endpoint(s) modified
Trial completed
Completion moved earlier: 2026-05-29 → 2026-03-31
NCT04432597 HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in… · National Cancer Institute (NCI) · Phase 1/2
2026-08-21
Primary endpoint(s) modified
Trial arms changed: 4 → 5
NCT05269381 Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for… · Mayo Clinic · Phase 1/2
2026-09-05
Primary endpoint(s) modified
Results posted: 2026-09-04
NCT05139368 Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer · University of Utah
2026-09-15
Enrollment closed, study ongoing
NCT05799274 Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other… · Radiopharm Theranostics, Ltd · Phase 1

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-09-11 NCT07815873 Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in… European Institute of Oncology new
2026-09-08 NCT07807202 Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire… Muso Health new
2026-08-31 NCT07795385 Embodied Conversational Agents for Cervical Cancer Screening Abnormalities Tufts Medical Center new
2026-08-25 NCT07784283 Integrating HPV Education Into School Health Programs in Cambodia and Kenya Clinton Health Access Initiative Inc. new
2026-08-24 NCT07782164 Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) Amsterdam UMC, location VUmc new
2026-08-24 NCT07781475 Spatially Fractionated Radiation Therapy for Locally Advanced Cervical Cancer The University of Hong Kong-Shenzhen Hospital new
2026-08-20 NCT07777094 TS Triage of HR-HPV Positive Population and Its Accuracy Study Affiliated Hospital of Nantong University new
2026-08-18 NCT07770100 Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy… Mark Bernard new Phase 2
2026-08-17 NCT07768787 Validation of Vaginal Self-Sampling With the Abbott Multi-Collect Swab for HPV Screening… AML new
2026-08-04 NCT07743918 Vitamin D Status and Clinical Outcomes in Locally Advanced Cervical Cancer University of Kragujevac new

Active trials by phase

Early Phase 1
3
Phase 1
62
Phase 1/2
50
Phase 2
146
Phase 2/3
8
Phase 3
41
Phase 4
13
Not charted: 398 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 721

NCT IDTitleSponsorStatusUpdated
Phase 4
NCT06952660 Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical… Pfizer Recruiting 2026-09-04
NCT07776821 An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent… Tianjin Medical University Cancer Institute and Hospital Recruiting 2026-08-25
NCT07645625 Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer University Medical Center Groningen Recruiting 2026-06-29
NCT04910802 Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden Miriam Elfström Recruiting 2021-09-16
NCT07801027 A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From… Merck Sharp & Dohme LLC Not Yet Recruiting 2026-09-03
NCT07768358 Tucatinib Continuation Study Pfizer Not Yet Recruiting 2026-08-28
NCT07015957 Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention New York University Active, Not Recruiting 2026-08-05
NCT06786429 Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental… Eunice Dube Not Yet Recruiting 2026-07-30
NCT05237947 Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in… National Cancer Institute (NCI) Active, Not Recruiting 2026-06-30
NCT07256912 A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC®… International Agency for Research on Cancer Not Yet Recruiting 2026-03-24
NCT07412873 Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for… Fundacion Clinic per a la Recerca Biomédica Not Yet Recruiting 2026-02-17
NCT03180034 Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of… National Cancer Institute (NCI) Active, Not Recruiting 2025-09-04
NCT06871787 Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses… Istanbul University Not Yet Recruiting 2025-03-14
Phase 3
NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… Merck Sharp & Dohme LLC Recruiting 2026-09-11
NCT07061977 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… National Cancer Institute (NCI) Recruiting 2026-09-08
NCT06079671 Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer… AstraZeneca Recruiting 2026-08-25
NCT05277688 Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer… Ruijin Hospital Recruiting 2026-08-18
NCT05581121 PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer Institut Claudius Regaud Recruiting 2026-07-07
NCT07400536 A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy… Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Recruiting 2026-05-13
NCT07168200 A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy… Shanghai Shengdi Pharmaceutical Co., Ltd Recruiting 2026-04-15
NCT07418749 A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With… Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting 2026-04-06
NCT06156514 Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally… National Institute of Cancerología Recruiting 2025-05-28
NCT06459687 Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or… Lee's Pharmaceutical Limited Recruiting 2025-05-14
NCT06641635 Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer Peking Union Medical College Hospital Recruiting 2025-03-18
NCT06692166 A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With… Mabwell (Shanghai) Bioscience Co., Ltd. Recruiting 2024-11-22
See all 721 active Cervical Cancer trials with filters →

Top sponsors by active trials in this area

M.D. Anderson Cancer Center (20) · National Cancer Institute (NCI) (16) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (13) · Peking Union Medical College Hospital (11) · Chongqing University Cancer Hospital (10) · Mayo Clinic (10) · Tata Memorial Hospital (9) · Fujian Cancer Hospital (8) · Obstetrics & Gynecology Hospital of Fudan University (8) · UNC Lineberger Comprehensive Cancer Center (8)

Get alerts when Cervical Cancer trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free